New heart valve procedure could offer hope for patients with leaky tricuspid valve
NCT ID NCT07321899
First seen Jan 09, 2026 · Last updated May 01, 2026 · Updated 18 times
Summary
This study tests a new device, the Medtronic Intrepid™ TTVR System, to replace the tricuspid valve without open-heart surgery in people with severe tricuspid regurgitation. About 1,186 participants will receive the valve and be followed for safety and quality of life. The goal is to reduce the backward flow of blood and improve symptoms.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE TRICUSPID REGURGITATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.